Skip to main content
. 2016 Aug 5;112(1):429–442. doi: 10.1093/cvr/cvw194

Figure 4.

Figure 4

Pathways involved in PCSK9-mediated inflammation. Intracellular PCSK9, including the internalized one which escapes lysosomal degradation could eventually undergoes re-secretion but exerts cytoplasmic effects that might regulate the expression of genes controlling inflammation (1). PCSK9 could also target LRP-1 which is involved in the activation of JAK/STAT and ERK pathways (2).